- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Allergy Immunotherapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Allergy Immunotherapies market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Allergic Rhinitis accounting for % of the Allergy Immunotherapies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Subcutaneous Immunotherapy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Allergy Immunotherapies include ALK, Stallergenes, HAL, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Allergy Immunotherapies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Market segment by Application, can be divided into
Allergic Rhinitis
Allergic Asthma
Other
Market segment by players, this report covers
ALK
Stallergenes
HAL
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Allergy Immunotherapies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Allergy Immunotherapies, with revenue, gross margin and global market share of Allergy Immunotherapies from 2019 to 2022.
Chapter 3, the Allergy Immunotherapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Allergy Immunotherapies market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Allergy Immunotherapies research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Allergy Immunotherapies
1.2 Classification of Allergy Immunotherapies by Type
1.2.1 Overview: Global Allergy Immunotherapies Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Allergy Immunotherapies Revenue Market Share by Type in 2021
1.2.3 Subcutaneous Immunotherapy
1.2.4 Sublingual Immunotherapy
1.3 Global Allergy Immunotherapies Market by Application
1.3.1 Overview: Global Allergy Immunotherapies Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Global Allergy Immunotherapies Market Size & Forecast
1.5 Global Allergy Immunotherapies Market Size and Forecast by Region
1.5.1 Global Allergy Immunotherapies Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Allergy Immunotherapies Market Size by Region, (2017-2022)
1.5.3 North America Allergy Immunotherapies Market Size and Prospect (2017-2028)
1.5.4 Europe Allergy Immunotherapies Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Allergy Immunotherapies Market Size and Prospect (2017-2028)
1.5.6 South America Allergy Immunotherapies Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Allergy Immunotherapies Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Allergy Immunotherapies Market Drivers
1.6.2 Allergy Immunotherapies Market Restraints
1.6.3 Allergy Immunotherapies Trends Analysis
2 Company Profiles
2.1 ALK
2.1.1 ALK Details
2.1.2 ALK Major Business
2.1.3 ALK Allergy Immunotherapies Product and Solutions
2.1.4 ALK Allergy Immunotherapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 ALK Recent Developments and Future Plans
2.2 Stallergenes
2.2.1 Stallergenes Details
2.2.2 Stallergenes Major Business
2.2.3 Stallergenes Allergy Immunotherapies Product and Solutions
2.2.4 Stallergenes Allergy Immunotherapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Stallergenes Recent Developments and Future Plans
2.3 HAL
2.3.1 HAL Details
2.3.2 HAL Major Business
2.3.3 HAL Allergy Immunotherapies Product and Solutions
2.3.4 HAL Allergy Immunotherapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 HAL Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Allergy Immunotherapies Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Allergy Immunotherapies Players Market Share in 2021
3.2.2 Top 10 Allergy Immunotherapies Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Allergy Immunotherapies Players Head Office, Products and Services Provided
3.4 Allergy Immunotherapies Mergers & Acquisitions
3.5 Allergy Immunotherapies New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Allergy Immunotherapies Revenue and Market Share by Type (2017-2022)
4.2 Global Allergy Immunotherapies Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Allergy Immunotherapies Revenue Market Share by Application (2017-2022)
5.2 Global Allergy Immunotherapies Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Allergy Immunotherapies Revenue by Type (2017-2028)
6.2 North America Allergy Immunotherapies Revenue by Application (2017-2028)
6.3 North America Allergy Immunotherapies Market Size by Country
6.3.1 North America Allergy Immunotherapies Revenue by Country (2017-2028)
6.3.2 United States Allergy Immunotherapies Market Size and Forecast (2017-2028)
6.3.3 Canada Allergy Immunotherapies Market Size and Forecast (2017-2028)
6.3.4 Mexico Allergy Immunotherapies Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Allergy Immunotherapies Revenue by Type (2017-2028)
7.2 Europe Allergy Immunotherapies Revenue by Application (2017-2028)
7.3 Europe Allergy Immunotherapies Market Size by Country
7.3.1 Europe Allergy Immunotherapies Revenue by Country (2017-2028)
7.3.2 Germany Allergy Immunotherapies Market Size and Forecast (2017-2028)
7.3.3 France Allergy Immunotherapies Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Allergy Immunotherapies Market Size and Forecast (2017-2028)
7.3.5 Russia Allergy Immunotherapies Market Size and Forecast (2017-2028)
7.3.6 Italy Allergy Immunotherapies Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Allergy Immunotherapies Revenue by Type (2017-2028)
8.2 Asia-Pacific Allergy Immunotherapies Revenue by Application (2017-2028)
8.3 Asia-Pacific Allergy Immunotherapies Market Size by Region
8.3.1 Asia-Pacific Allergy Immunotherapies Revenue by Region (2017-2028)
8.3.2 China Allergy Immunotherapies Market Size and Forecast (2017-2028)
8.3.3 Japan Allergy Immunotherapies Market Size and Forecast (2017-2028)
8.3.4 South Korea Allergy Immunotherapies Market Size and Forecast (2017-2028)
8.3.5 India Allergy Immunotherapies Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Allergy Immunotherapies Market Size and Forecast (2017-2028)
8.3.7 Australia Allergy Immunotherapies Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Allergy Immunotherapies Revenue by Type (2017-2028)
9.2 South America Allergy Immunotherapies Revenue by Application (2017-2028)
9.3 South America Allergy Immunotherapies Market Size by Country
9.3.1 South America Allergy Immunotherapies Revenue by Country (2017-2028)
9.3.2 Brazil Allergy Immunotherapies Market Size and Forecast (2017-2028)
9.3.3 Argentina Allergy Immunotherapies Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Allergy Immunotherapies Revenue by Type (2017-2028)
10.2 Middle East & Africa Allergy Immunotherapies Revenue by Application (2017-2028)
10.3 Middle East & Africa Allergy Immunotherapies Market Size by Country
10.3.1 Middle East & Africa Allergy Immunotherapies Revenue by Country (2017-2028)
10.3.2 Turkey Allergy Immunotherapies Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Allergy Immunotherapies Market Size and Forecast (2017-2028)
10.3.4 UAE Allergy Immunotherapies Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Allergy Immunotherapies Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Allergy Immunotherapies Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Allergy Immunotherapies Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Allergy Immunotherapies Revenue (USD Million) by Region (2017-2022)
Table 5. Global Allergy Immunotherapies Revenue Market Share by Region (2023-2028)
Table 6. ALK Corporate Information, Head Office, and Major Competitors
Table 7. ALK Major Business
Table 8. ALK Allergy Immunotherapies Product and Solutions
Table 9. ALK Allergy Immunotherapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Stallergenes Corporate Information, Head Office, and Major Competitors
Table 11. Stallergenes Major Business
Table 12. Stallergenes Allergy Immunotherapies Product and Solutions
Table 13. Stallergenes Allergy Immunotherapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. HAL Corporate Information, Head Office, and Major Competitors
Table 15. HAL Major Business
Table 16. HAL Allergy Immunotherapies Product and Solutions
Table 17. HAL Allergy Immunotherapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Global Allergy Immunotherapies Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 19. Global Allergy Immunotherapies Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 20. Breakdown of Allergy Immunotherapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Allergy Immunotherapies Players Head Office, Products and Services Provided
Table 22. Allergy Immunotherapies Mergers & Acquisitions in the Past Five Years
Table 23. Allergy Immunotherapies New Entrants and Expansion Plans
Table 24. Global Allergy Immunotherapies Revenue (USD Million) by Type (2017-2022)
Table 25. Global Allergy Immunotherapies Revenue Share by Type (2017-2022)
Table 26. Global Allergy Immunotherapies Revenue Forecast by Type (2023-2028)
Table 27. Global Allergy Immunotherapies Revenue by Application (2017-2022)
Table 28. Global Allergy Immunotherapies Revenue Forecast by Application (2023-2028)
Table 29. North America Allergy Immunotherapies Revenue by Type (2017-2022) & (USD Million)
Table 30. North America Allergy Immunotherapies Revenue by Type (2023-2028) & (USD Million)
Table 31. North America Allergy Immunotherapies Revenue by Application (2017-2022) & (USD Million)
Table 32. North America Allergy Immunotherapies Revenue by Application (2023-2028) & (USD Million)
Table 33. North America Allergy Immunotherapies Revenue by Country (2017-2022) & (USD Million)
Table 34. North America Allergy Immunotherapies Revenue by Country (2023-2028) & (USD Million)
Table 35. Europe Allergy Immunotherapies Revenue by Type (2017-2022) & (USD Million)
Table 36. Europe Allergy Immunotherapies Revenue by Type (2023-2028) & (USD Million)
Table 37. Europe Allergy Immunotherapies Revenue by Application (2017-2022) & (USD Million)
Table 38. Europe Allergy Immunotherapies Revenue by Application (2023-2028) & (USD Million)
Table 39. Europe Allergy Immunotherapies Revenue by Country (2017-2022) & (USD Million)
Table 40. Europe Allergy Immunotherapies Revenue by Country (2023-2028) & (USD Million)
Table 41. Asia-Pacific Allergy Immunotherapies Revenue by Type (2017-2022) & (USD Million)
Table 42. Asia-Pacific Allergy Immunotherapies Revenue by Type (2023-2028) & (USD Million)
Table 43. Asia-Pacific Allergy Immunotherapies Revenue by Application (2017-2022) & (USD Million)
Table 44. Asia-Pacific Allergy Immunotherapies Revenue by Application (2023-2028) & (USD Million)
Table 45. Asia-Pacific Allergy Immunotherapies Revenue by Region (2017-2022) & (USD Million)
Table 46. Asia-Pacific Allergy Immunotherapies Revenue by Region (2023-2028) & (USD Million)
Table 47. South America Allergy Immunotherapies Revenue by Type (2017-2022) & (USD Million)
Table 48. South America Allergy Immunotherapies Revenue by Type (2023-2028) & (USD Million)
Table 49. South America Allergy Immunotherapies Revenue by Application (2017-2022) & (USD Million)
Table 50. South America Allergy Immunotherapies Revenue by Application (2023-2028) & (USD Million)
Table 51. South America Allergy Immunotherapies Revenue by Country (2017-2022) & (USD Million)
Table 52. South America Allergy Immunotherapies Revenue by Country (2023-2028) & (USD Million)
Table 53. Middle East & Africa Allergy Immunotherapies Revenue by Type (2017-2022) & (USD Million)
Table 54. Middle East & Africa Allergy Immunotherapies Revenue by Type (2023-2028) & (USD Million)
Table 55. Middle East & Africa Allergy Immunotherapies Revenue by Application (2017-2022) & (USD Million)
Table 56. Middle East & Africa Allergy Immunotherapies Revenue by Application (2023-2028) & (USD Million)
Table 57. Middle East & Africa Allergy Immunotherapies Revenue by Country (2017-2022) & (USD Million)
Table 58. Middle East & Africa Allergy Immunotherapies Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Allergy Immunotherapies Picture
Figure 2. Global Allergy Immunotherapies Revenue Market Share by Type in 2021
Figure 3. Subcutaneous Immunotherapy
Figure 4. Sublingual Immunotherapy
Figure 5. Allergy Immunotherapies Revenue Market Share by Application in 2021
Figure 6. Allergic Rhinitis Picture
Figure 7. Allergic Asthma Picture
Figure 8. Other Picture
Figure 9. Global Allergy Immunotherapies Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Allergy Immunotherapies Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Allergy Immunotherapies Revenue Market Share by Region (2017-2028)
Figure 12. Global Allergy Immunotherapies Revenue Market Share by Region in 2021
Figure 13. North America Allergy Immunotherapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Allergy Immunotherapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Allergy Immunotherapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Allergy Immunotherapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Allergy Immunotherapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Allergy Immunotherapies Market Drivers
Figure 19. Allergy Immunotherapies Market Restraints
Figure 20. Allergy Immunotherapies Market Trends
Figure 21. ALK Recent Developments and Future Plans
Figure 22. Stallergenes Recent Developments and Future Plans
Figure 23. HAL Recent Developments and Future Plans
Figure 24. Global Allergy Immunotherapies Revenue Share by Players in 2021
Figure 25. Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 26. Global Top 3 Players Allergy Immunotherapies Revenue Market Share in 2021
Figure 27. Global Top 10 Players Allergy Immunotherapies Revenue Market Share in 2021
Figure 28. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 29. Global Allergy Immunotherapies Revenue Share by Type in 2021
Figure 30. Global Allergy Immunotherapies Market Share Forecast by Type (2023-2028)
Figure 31. Global Allergy Immunotherapies Revenue Share by Application in 2021
Figure 32. Global Allergy Immunotherapies Market Share Forecast by Application (2023-2028)
Figure 33. North America Allergy Immunotherapies Sales Market Share by Type (2017-2028)
Figure 34. North America Allergy Immunotherapies Sales Market Share by Application (2017-2028)
Figure 35. North America Allergy Immunotherapies Revenue Market Share by Country (2017-2028)
Figure 36. United States Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 37. Canada Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 38. Mexico Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 39. Europe Allergy Immunotherapies Sales Market Share by Type (2017-2028)
Figure 40. Europe Allergy Immunotherapies Sales Market Share by Application (2017-2028)
Figure 41. Europe Allergy Immunotherapies Revenue Market Share by Country (2017-2028)
Figure 42. Germany Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. France Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. United Kingdom Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Russia Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Italy Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Asia-Pacific Allergy Immunotherapies Sales Market Share by Type (2017-2028)
Figure 48. Asia-Pacific Allergy Immunotherapies Sales Market Share by Application (2017-2028)
Figure 49. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Region (2017-2028)
Figure 50. China Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Japan Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. South Korea Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. India Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Southeast Asia Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Australia Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. South America Allergy Immunotherapies Sales Market Share by Type (2017-2028)
Figure 57. South America Allergy Immunotherapies Sales Market Share by Application (2017-2028)
Figure 58. South America Allergy Immunotherapies Revenue Market Share by Country (2017-2028)
Figure 59. Brazil Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Argentina Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Middle East and Africa Allergy Immunotherapies Sales Market Share by Type (2017-2028)
Figure 62. Middle East and Africa Allergy Immunotherapies Sales Market Share by Application (2017-2028)
Figure 63. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Country (2017-2028)
Figure 64. Turkey Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Saudi Arabia Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. UAE Allergy Immunotherapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Methodology
Figure 68. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
